The application discloses an egg
yolk protein-derived
tripeptide with the function of improving
osteoporosis and application thereof, and belongs to the technical field of biological medicines. The
tripeptide is a
tripeptide APW with an
amino acid sequence of Ala-Pro-Trp. The
peptide segment can be obtained by artificial synthesis or directional enzymolysis of defatted egg
yolk powder. Function
verification shows that the tripeptide APW and egg
yolk protein enzymolysis products containing the
peptide segment have the function of improving
bone density. In a zebra fish
osteoporosis model, when the egg yolk
protein enzymolysis product is 20 μg / mL, the
bone density is increased by 58%; when the tripeptide APW is 0.5 μg / mL, the
bone density is increased by 23.4%; in a rat
osteoporosis model, when 10 mg / kg.d of the egg yolk protein enzymolysis product is eaten, the bone density of the
femur is increased by 3.39%. Moreover, the food-derived
bioactive peptide has high
biological safety, so the tripeptide APW and the egg yolk protein enzymolysis product containing the
peptide segment can be applied to the preparation of medicines for treating osteoporosis or health care foods for improving bone density, and have good market prospects and application potential.